
zzso cancer vaccines to treat solid tumors is not an easy zzso As solid tumors zzso the immune system places cancer cells under selective zzso it detects those that are more zzso zzso selecting those cells that are not recognized by the immune system and are therefore resistant to immune zzso zzso cells survive, and in turn their clones will spread to distant zzso This phenomenon, called zzso zzso is not novel, but is quite similar in principle to the selective pressure induced by chemotherapy and hormone therapy, and is zzso based on the zzso zzso and molecular instability present in most solid zzso This explains, at least in part, why many cancer vaccines work in animal models but not in a clinical zzso The aim of this article is to review the most commonly used cancer vaccine strategies and to evaluate the evidence supporting their zzso This is not as easy at it may sound, as each research group involved in cancer vaccine development uses different technologies, targets different zzso combines different carriers and zzso to obtain an immune response, and zzso patients with different administration zzso The final picture is somewhat zzso and comparison of different vaccine strategies is almost zzso Most of the vaccines are still zzso far from being approved by regulatory authorities, and their clinical utility is almost zzso 

